Melanie Kelly
Chief Tech/Sci/R&D Officer bij Panag Pharma, Inc.
Profiel
Melanie Kelly is currently the Executive Director & Member of the International Cannabinoid Research Society, Director at The Canadian Consortium for the Investigation of Cannabinoids, Professor at Dalhousie University, and Chief Scientific Officer at Panag Pharma, Inc. She was formerly the Chief Scientific Officer at Tetra Bio-Pharma, Inc.
Actieve functies van Melanie Kelly
| Bedrijven | Functie | Begin |
|---|---|---|
| Dalhousie University | Corporate Officer/Principal | 01-07-1991 |
| International Cannabinoid Research Society | Director/Board Member | 01-07-2017 |
| The Canadian Consortium for the Investigation of Cannabinoids | Director/Board Member | - |
Panag Pharma, Inc.
 Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada. | Chief Tech/Sci/R&D Officer | 01-07-2014 |
Eerdere bekende functies van Melanie Kelly
| Bedrijven | Functie | Einde |
|---|---|---|
| TETRA BIO-PHARMA INC. | Chief Tech/Sci/R&D Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| International Cannabinoid Research Society | |
| The Canadian Consortium for the Investigation of Cannabinoids | |
Panag Pharma, Inc.
Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada. | Health Technology |
